Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

NCT02025608 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Pramipexole
DRUG: Placebo

Sponsor

Mauro Manconi

Collaborators

[object Object]
[object Object]